[1]
Bong, S.-T., Law, L.N.-S. and Law, J.W.-F. 2019. A review on the potential of Bruton’s tyrosine kinase (Btk) inhibitor – Ibrutinib for treatment of Multiple Myeloma (MM). Progress In Microbes & Molecular Biology. 2, 1 (May 2019). DOI:https://doi.org/10.36877/pmmb.a0000028.